PMN
ProMIS Neurosciences Inc. · Healthcare · Market cap $29.7M
Insiders bought $74K net in the last 90 days ·0 sellers, 3 buyers· latest Form 4 filed Nov 3, 2026
Insider Buying
$8.8M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
5
in the rolling window
Latest filing
Nov 3, 2026
Williams Eugene
ProMIS Neurosciences Inc. (PMN) has 13 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 5 distinct insiders. Most recent filing: Nov 3, 2026.
Inside the rolling window, 5 insiders at ProMIS Neurosciences Inc. reported 10 open-market purchases totaling $8.8M and no open-market sales. The most active filer is Director Williams Eugene with 5 filings. The most recent open-market filing is a purchase of 1,316 shares by Director Williams Eugene, dated Oct 30, 2026, worth $5K.
- Industry:Biotechnology
- CEO:Neil K. Warma
- Employees:11
- HQ:Toronto, ON, CA
- IPO:2007-01-10
| Source | |||||||
|---|---|---|---|---|---|---|---|
Williams EugeneFirst in 8 months | Director | Purchase | 1,316 | $5K | Nov 3 | — | SEC ↗ |
Cashman NeilFirst filing | Chief Scientific Officer | Purchase | 10,000 | $39K | Nov 3 | — | SEC ↗ |
Kaplan JohanneFirst in 6 months | Chief Development Officer | Purchase | 2,280 | $30K | Aug 7 | -77.5% | SEC ↗ |
Kirwin Patrick D.First filing | Director | Purchase | 4,000 | $45K | Apr 23 | -69.6% | SEC ↗ |
| Director | Purchase | 2,000 | $49K | Mar 6 | -85.9% | SEC ↗ | |
Williams EugeneFirst filing | Director | Purchase | 1,000 | $23K | Mar 4 | -86.2% | SEC ↗ |
Williams EugeneFirst filing | Director | Purchase | 1,000 | $22K | Mar 4 | -86.2% | SEC ↗ |
Williams EugeneFirst filing | Director | Purchase | 2,000 | $48K | Mar 4 | -86.2% | SEC ↗ |
Kaplan JohanneFirst filing | Chief Development Officer | Purchase | 1,629 | $25K | Feb 23 | -79.0% | SEC ↗ |
ABG Management Ltd.First filing | 10% Owner | Purchase | 700,741 | $8.5M | Feb 5 | -74.7% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does PMN have?
ProMIS Neurosciences Inc. (PMN) has 13 SEC Form 4 filings (15 transaction rows) in the rolling 365-day window, disclosed by 5 distinct insiders. Most recent filing: Nov 3, 2026.
When was the most recent SEC Form 4 filing for PMN?
The most recent Form 4 filing for PMN on Tracefour is dated Nov 3, 2026.
Who is the most active insider at PMN?
The most active SEC Form 4 filer at PMN in the rolling window is Director Williams Eugene, with 5 filings.
What is the net insider flow at PMN over the last 6 months?
Over the trailing 180 days, insiders at PMN have net bought $74K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at PMN in the current window?
Inside the rolling window, insiders at PMN bought $8.8M and sold $0 based on SEC Form 4 filings.
Can I get alerts for PMN insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at ProMIS Neurosciences Inc. (PMN). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
ProMIS Neurosciences Inc. is in the Healthcare sector.